2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY



Similar documents
Measure #12 (NQF 0086): Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation National Quality Strategy Domain: Effective Clinical Care

DENOMINATOR: All female patients aged 65 years and older with a diagnosis of urinary incontinence

Measure #41: Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older National Quality Strategy Domain: Effective Clinical Care

Measure #145: Radiology: Exposure Time Reported for Procedures Using Fluoroscopy National Quality Strategy Domain: Patient Safety

Measure #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care

Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care

Measure #112 (NQF 2372): Breast Cancer Screening National Quality Strategy Domain: Effective Clinical Care

Measure #430: Prevention of Post-Operative Nausea and Vomiting (PONV) Combination Therapy National Quality Strategy Domain: Patient Safety

Measure #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Measure #420: Varicose Vein Treatment with Saphenous Ablation: Outcome Survey National Quality Strategy Domain: Effective Clinical Care

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Measure #370 (NQF 0710): Depression Remission at Twelve Months National Quality Strategy Domain: Effective Clinical Care

Physician Quality Reporting System (PQRS)

Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor Control National Quality Strategy Domain: Effective Clinical Care

Measure #130 (NQF 0419): Documentation of Current Medications in the Medical Record National Quality Strategy Domain: Patient Safety

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

AAAAI Allergy, Asthma & Immunology Quality Clinical Data Registry in collaboration with CECity

2016 Physician Quality Reporting System (PQRS) Measure Specification and Measure Flow Guide for Claims and Registry Reporting of Individual Measures

INFLAMMATORY BOWEL DISEASE (IBD) MEASURES GROUP OVERVIEW

OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS FOR MEASURES GROUPS:

Patient sample criteria for the OPEIR Measures Group are all patients regardless of age, that have a specific CT procedure performed:

VIII. Dentist Crosswalk

Simply Podiatry PQRS Measures Summary

Therefore, a physician should only bill for new patient services when the elements of the definition is met.

Understanding Coding & Reimbursement for SBI. Presented By: Jen Cohrs CPC, CPMA, CGIC Director of Educational Strategies Wisconsin Medical Society

Understanding how to use the Quality Measure Step by Step Documents

Meaningful Use Qualification Plan

CPT Coding Update And Other Issues

Health risk assessment: a standardized framework

2013 Physician Quality Reporting System (PQRS): Implementation Guide Claims-Based Reporting for Incentive

The Centers for Medicare & Medicaid Services (CMS) seeks stakeholder comments on the following clinical quality measure under development:

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology

INTRODUCTION. Tobacco Prevention & Cessation Program Substance Abuse and Tobacco Cessation Report - March 2011

Meaningful Use - The Basics

Purdue Research Foundation

Meaningful Use Reporting Quick Reference

2016 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older)

TOBACCO CESSATION WORKS: AN OVERVIEW OF BEST PRACTICES AND STATE EXPERIENCES

"Starting today, every doctor, nurse, health plan, purchaser, and medical school in America should make treating tobacco dependence a top priority.

AQI QCDR Measure Specification

The HITECH Act and Meaningful Use Implications for Population and Public Health

Presented by. Terri Gonzalez Director of Practice Improvement North Carolina Medical Society

Remote Access Technologies/Telehealth Services Medicare Effective January 1, 2016

MEANINGFUL USE STAGE 2 USERS GUIDE

Mark Anderson, FHIMSS, CPHIMSS Healthcare IT Futurist

How to use the Brief Tobacco Cessation Intervention Form

Quit & Get Fit! Frequently Asked Questions For Personal Trainers (November 2011)

PREVENTIVE MEDICINE AND SCREENING POLICY

Ophthalmology Meaningful Use Attestation Guide Stage Edition

MEANINGFUL USE STAGE QUICK REFERENCE GUIDE

Beacon User Stories Version 1.0

Meaningful Use Stage 2 Implementation Guide

Meaningful Use Objectives

Core Set of Children s Health Care Quality Measures for Medicaid and CHIP (Child Core Set)

STAGES 1 AND 2 REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1

Questions & Answers on ACA Section 4106 Improving Access to Preventive Services for Eligible Adults in Medicaid

Achieving Quality and Value in Chronic Care Management

How to Approach a Study: Concepts, Hypotheses, and Theoretical Frameworks. Lynda Burton, ScD Johns Hopkins University

Eligible Professionals please see the document: MEDITECH Prepares You for Stage 2 of Meaningful Use: Eligible Professionals.

NY Medicaid EHR Incentive Program. Eligible Professionals Meaningful Use Stage 2 (MU2) Webinar

RECOMMENDATIONS FOR DEFINING AND DEMONSTRATING MEANINGFUL USE OF CERTIFIED ELECTRONIC HEALTH RECORDS (EHRs)

PQRS Cheat Sheet. Occupational Therapy Reporting- Individual Measures

2014 Physician Quality Reporting System (PQRS): Implementation Guide 12/13/2013

Meaningful use. Meaningful data. Meaningful care. The 3M Healthcare Data Dictionary: Standardizing lab data to LOINC for meaningful use

The American Recovery and Reinvestment Act of 2009, Meaningful Use and the Impact on Netsmart s Public Health Clients

FPL Global Fixed Income Committee

Meaningful Use: Registration, Attestation, Workflow Tips and Tricks

2015 Physician Quality Reporting System (PQRS): Implementation Guide

AvMed s Physician-to- Physician Referral Program

Clinical Policy Guideline

Electronic Health Record (EHR) Incentive Program. Stage 2 Final Rule Update Part 2

Meaningful Use Stage 2 Certification: A Guide for EHR Product Managers

0 What is Meaningful Use and where are we? 0 What is the Physician Quality Reporting System and where stage are we on?

Welcome to the Data Analytics Toolkit PowerPoint presentation on clinical quality measures, meaningful use, and data analytics.

MASSACHUSETTS TOBACCO TREATMENT SPECIALIST TRAINING

Transcription:

Measure #226 (NQF 0028): Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received cessation counseling intervention if identified as a tobacco user INSTRUCTIONS: This measure is to be reported once per reporting period for patients seen during the reporting period. This measure is intended to reflect the quality of services provided for preventive screening for tobacco use. Measure Reporting via Claims: CPT or HCPCS codes and patient demographics are used to identify patients who are included in the measure s denominator. CPT Category II codes are used to report the numerator of the measure. When reporting the measure via claims, submit the appropriate CPT or HCPCS codes, and the appropriate CPT Category II code OR the CPT Category II code with the modifier. The modifiers allowed for this measure are: 1Pmedical reasons, 8P- reason not otherwise specified. All measure-specific coding should be reported on the claim(s) representing the eligible encounter. Measure Reporting via Registry: CPT or HCPCS codes and patient demographics are used to identify patients who are included in the measure s denominator. The listed numerator options are used to report the numerator of the measure. The quality-data codes listed do not need to be submitted for registry-based submissions; however, these codes may be submitted for those registries that utilize claims data. DENOMINATOR: All patients aged 18 years and older Denominator Criteria (Eligible Cases): Patients aged 18 years on date of encounter AND Patient encounter during the reporting period (CPT or HCPCS): 90791, 90792, 90832, 90834, 90837, 90845, 92002, 92004, 92012, 92014, 92521, 92522, 92523, 92524, 92540, 92557, 92625, 96150, 96151, 96152, 97003, 97004, 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99406, 99407, G0438, G0439 NUMERATOR: Patients who were screened for tobacco use at least once within 24 months AND who received tobacco cessation intervention if identified as a tobacco user Definitions: Tobacco Use Includes use of any type of tobacco. Tobacco Cessation Intervention Includes brief counseling (3 minutes or less), and/or pharmacotherapy. NUMERATOR NOTE: In the event that a patient is screened for tobacco use and identified as a user but did not receive tobacco cessation intervention report 4004F with 8P. Numerator Quality-Data Coding Options for Reporting Satisfactorily: 11/17/2015 Page 1 of 6

OR OR Patient Screened for Tobacco Use, Identified as a User and Received Intervention Performance Met: CPT II 4004F: Patient screened for tobacco use AND received tobacco cessation intervention (counseling, pharmacotherapy, or both), if identified as a tobacco user OR Patient Screened for Tobacco Use and Identified as a Non-User of Tobacco Performance Met: CPT II 1036F: Current tobacco non-user Tobacco Screening not Performed for Medical Reasons Append a modifier (1P) to CPT Category II code 4004F to report documented circumstances that appropriately exclude patients from the denominator Medical Performance Exclusion: 4004F with 1P: Documentation of medical reason(s) for not screening for tobacco use (eg, limited life expectancy, other medical reasons) Tobacco Screening OR Tobacco Cessation Intervention not Performed, Reason Not Otherwise Specified Append a reporting modifier (8P) to CPT Category II code 4004F to report circumstances when the action described in the numerator is not performed and the reason is not otherwise specified. Performance Not Met: 4004F with 8P: Tobacco screening OR tobacco cessation intervention not performed, reason not otherwise specified RATIONALE: This measure is intended to promote adult tobacco screening and tobacco cessation interventions for those who use tobacco products. There is good evidence that tobacco screening and brief cessation intervention (including counseling and/or pharmacotherapy) is successful in helping tobacco users quit. Tobacco users who are able to stop smoking lower their risk for heart disease, lung disease, and stroke. CLINICAL RECOMMENDATION STATEMENTS: The following evidence statements are quoted verbatim from the referenced clinical guidelines: All patients should be asked if they use tobacco and should have their tobacco use status documented on a regular basis. Evidence has shown that clinic screening systems, such as expanding the vital signs to include tobacco use status or the use of other reminder systems such as chart stickers or computer prompts, significantly increase rates of clinician intervention. (Strength of Evidence = A) (U.S. Department of Health and Human Services. Public Health Service, 2008) All physicians should strongly advise every patient who smokes to quit because evidence shows that physician advice to quit smoking increases abstinence rates. (Strength of Evidence = A) (U.S. Department of Health and Human Services. Public Health Service, 2008) Minimal interventions lasting less than 3 minutes increase overall tobacco abstinence rates. Every tobacco user should be offered at least a minimal intervention, whether or not he or she is referred to an intensive intervention. (Strength of Evidence = A) (U.S. Department of Health and Human Services. Public Health Service, 2008) The combination of counseling and medication is more effective for smoking cessation than either medication or counseling alone. Therefore, whenever feasible and appropriate, both counseling and medication should be provided to patients trying to quit smoking. (Strength of Evidence = A) (U.S. Department of Health and Human Services. Public Health Service, 2008) Clinicians should encourage all patients attempting to quit to use effective medications for tobacco dependence treatment, except where contraindicated or for specific populations for which there is insufficient evidence of 11/17/2015 Page 2 of 6

effectiveness (ie, pregnant women, smokeless tobacco users, light smokers, and adolescents). (Strength of Evidence = A) (U.S. Department of Health and Human Services. Public Health Service, 2008) The USPSTF recommends that clinicians ask all adults about tobacco use and provide tobacco cessation interventions for those who use tobacco products. (A Recommendation) (U.S. Preventive Services Task Force, 2009) COPYRIGHT: Physician Performance Measures (Measures) and related data specifications, developed by the American Medical Association (AMA)-convened Physician Consortium for Performance Improvement (PCPI ), are intended to facilitate quality improvement activities by physicians. These Measures are intended to assist physicians in enhancing quality of care. Measures are designed for use by any physician who manages the care of a patient for a specific condition or for prevention. These performance Measures are not clinical guidelines and do not establish a standard of medical care. The PCPI has not tested its Measures for all potential applications. The PCPI encourages the testing and evaluation of its Measures. Measures are subject to review and may be revised or rescinded at any time by the PCPI. The Measures may not be altered without the prior written approval of the PCPI. Measures developed by the PCPI, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, eg, use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and American Medical Association, on behalf of the PCPI. Neither the PCPI nor its members shall be responsible for any use of these Measures. THE MEASURES ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND. 2007 American Medical Association. All Rights Reserved. Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, the PCPI and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT ) or other coding contained in the specifications. THE SPECIFICATIONS ARE PROVIDED AS IS WITHOUT WARRANTY OF ANY KIND. CPT contained in the Measures specifications is copyright 2004-2015 American Medical Association. LOINC copyright 2004-2015 Regenstrief Institute, Inc. SNOMED CLINICAL TERMS (SNOMED CT ) copyright 2004-2015 International Health Terminology Standards Development Organization. All Rights Reserved. Use of SNOMED CT is only authorized within the United States. 11/17/2015 Page 3 of 6

11/17/2015 Page 4 of 6

2016 Claims/Registry Individual Measure Flow PQRS #226 NQF #0028: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Please refer to the specific section of the Measure Specification to identify the denominator and numerator information for use in reporting this Individual Measure. 1. Start with Denominator 2. Check Patient Age: a. If the Age is greater than or equal to 18 years of age on Date of Service equals No during the measurement period, do not include in Eligible Patient Population. Stop Processing. b. If the Age is greater than or equal to 18 years of age on Date of Service equals Yes during the measurement period, proceed to check Encounter Performed. 3. Check Encounter Performed: a. If Encounter as Listed in the Denominator equals No, do not include in Eligible Patient Population. Stop Processing. b. If Encounter as Listed in the Denominator equals Yes, include in the Eligible Population. 4. Denominator Population: a. Denominator population is all Eligible Patients in the denominator. Denominator is represented as Denominator in the Sample Calculation listed at the end of this document. Letter d equals 8 patients in the sample calculation. 5. Start Numerator 6. Check Patient Screened for Tobacco Use, Identified as a User and Received Intervention: a. If Patient Screened for Tobacco Use, Identified as a User and Received Intervention equals Yes, include in Reporting Met and Performance Met. b. Reporting Met and Performance Met letter is represented in the Reporting Rate and Performance Rate in the Sample Calculation listed at the end of this document. Letter a1 equals 1 patient in Sample Calculation. c. If Patient Screened for Tobacco Use, Identified as User and and Received Intervention equals No, proceed to Patient Screened for Tobacco Use and Identified as a Non-User of Tobacco. 7. Check Patient Screened for Tobacco Use and Identified as a Non-User of Tobacco: a. If Patient Screened for Tobacco Use and Identified as a Non-User of Tobacco equals Yes, include in Reporting Met and Performance Met. b. Reporting Met and Performance Met letter is represented in the Reporting Rate and Performance Rate in the Sample Calculation listed at the end of this document. Letter a2 equals 2 patients in Sample Calculation. 11/17/2015 Page 5 of 6

c. If Patient Screened for Tobacco Use and Identified as a Non-User of Tobacco equals No, proceed to Tobacco Screening Not performed for Medical Reason(s). 8. Check Tobacco Screening Not Performed for Medical Reason(s): a. If Tobacco Screening Not Performed for Medical Reason(s) equals Yes, include in Reporting Met and Performance Exclusion. b. Reporting Met and Performance Exclusion letter is represented in the Reporting Rate and Performance Rate in the Sample Calculation listed at the end of this document. Letter b equals 2 patients in the Sample Calculation. c. If Tobacco Screening Not Performed for Medical Reason(s) equals No, proceed to Tobacco Screening or Tobacco Cessation Intervention Not Performed, Reason Not Specified. 9. Check Tobacco Screening or Tobacco Cessation Intervention Not Performed, Reason Not Specified: a. If Tobacco Screening or Tobacco Cessation Intervention Not Performed, Reason Not Specified equals Yes, include in the Reporting Met and Performance Not Met. b. Reporting Met and Performance Not Met letter is represented in the Reporting Rate in the Sample Calculation listed at the end of this document. Letter c equals 2 patients in the Sample Calculation. c. If Tobacco Screening or Tobacco Cessation Intervention Not Performed, Reason Not Specified equals No, proceed to Reporting Not Met. 10. Check Reporting Not Met a. If Reporting Not Met equals No, Quality Data Code or equivalent not reported. 1 patient has been subtracted from the reporting numerator in the sample calculation. 11/17/2015 Page 6 of 6